Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 11 Aug 2023

A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma

in Cancer Immunity and Immunotherapy

Kirti Pandey
Stacie S. Wang
Nicole A. Mifsud
Pouya Faridi
Alexander J. Davenport
Andrew I. Webb
Jarrod J. Sandow
Rochelle Ayala
Michelle Monje
Ryan S. Cross

Frontiers in Oncology

doi 10.3389/fonc.2023.1192448

11,111 views
7 citations

Case Report

Published on 10 Aug 2023

Bilateral orbital plasmacytomas as first sign of extramedullary progression post CAR-T therapy: case report and literature review

in Cancer Immunity and Immunotherapy

Javier Nogués-Castell
Silvia Feu-Basilio
Óscar Felguera García
Carlos Fernández de Larrea
Aina Oliver-Caldés
Olga Balagué Ponz
Jessica Matas Fassi

Frontiers in Oncology

doi 10.3389/fonc.2023.1217714

2,263 views
1 citation

Systematic Review

Published on 09 Aug 2023

Prognostic role of IL-8 in cancer patients treated with immune checkpoint inhibitors: a system review and meta-analysis

in Cancer Immunity and Immunotherapy

Dan Zou
Ailin Song
Wei Yong

Frontiers in Oncology

doi 10.3389/fonc.2023.1176574

2,096 views
7 citations

Editorial

Published on 08 Aug 2023

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors

in Cancer Immunity and Immunotherapy

Stefano Ugel
Chiara Bazzichetto
Fabiana Conciatori

Frontiers in Oncology

doi 10.3389/fonc.2023.1260183

1,126 views

Original Research

Published on 02 Aug 2023

Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma

in Cancer Immunity and Immunotherapy

Bicheng Ye
Qi Wang
Xiaofeng Zhu
Lingling Zeng
Huiyuan Luo
Yan Xiong
Qin Li
Qinmei Zhu
Songyun Zhao
Ting Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1236435

5,869 views
11 citations

Review

Published on 31 Jul 2023

Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery

in Cancer Immunity and Immunotherapy

Elizabeth Mazzio
Andrew Barnes
Ramesh Badisa
Stevie Council
Karam F. A. Soliman

Frontiers in Oncology

doi 10.3389/fonc.2023.1180084

6,543 views
3 citations

Original Research

Published on 28 Jul 2023

BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy

in Cancer Immunity and Immunotherapy

Shizhong Liang
Dandan Zheng
Xiong Liu
Xiong Mei
Congcong Zhou
Cuizhen Xiao
Chao Qin
Haitao Yue
Jian Lin
Cuihua Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1211759

5,611 views
5 citations

Original Research

Published on 20 Jul 2023

An oxidative stress biomarkers predict prognosis in gastric cancer patients receiving immune checkpoint inhibitor

in Cancer Immunity and Immunotherapy

Guiming Deng
Hao Sun
Rong Huang
Hongming Pan
Yanjiao Zuo
Ruihu Zhao
Zhongze Du
Yingwei Xue
Hongjiang Song

Frontiers in Oncology

doi 10.3389/fonc.2023.1173266

1,851 views
2 citations

Review

Published on 19 Jul 2023

Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer

in Cancer Immunity and Immunotherapy

Emily A. Henderson
Slawomir Lukomski
Brian A. Boone

Frontiers in Oncology

doi 10.3389/fonc.2023.1217095

4,968 views
5 citations

Original Research

Published on 18 Jul 2023

Real-world study of PD-1/L1 immune checkpoint inhibitors for advanced non-small cell lung cancer after resistance to EGFR-TKIs

in Cancer Immunity and Immunotherapy

Kunchen Wei
Chao Zhou
Yang Chen
Xiao Feng
Hao Tang

Frontiers in Oncology

doi 10.3389/fonc.2023.1217872

2,863 views
1 citation

Original Research

Published on 18 Jul 2023

A novel machine learning-based programmed cell death-related clinical diagnostic and prognostic model associated with immune infiltration in endometrial cancer

in Cancer Immunity and Immunotherapy

Jian Xiong
Junyuan Chen
Zhongming Guo
Chaoyue Zhang
Li Yuan
Kefei Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1224071

3,391 views

Original Research

Published on 17 Jul 2023

Aggrephagy-related patterns in tumor microenvironment, prognosis, and immunotherapy for acute myeloid leukemia: a comprehensive single-cell RNA sequencing analysis

in Cancer Immunity and Immunotherapy

Yan Pan
Yingjian Wang
Mengsi Hu
Shoufang Xu
Feiyu Jiang
Yetao Han
Fangjian Chen
Zhiwei Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1195392

3,228 views
7 citations

Original Research

Published on 14 Jul 2023

A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC

in Cancer Immunity and Immunotherapy

Yue Xi
Yingchun Zhang
Kun Zheng
Jiawei Zou
Lv Gui
Xin Zou
Liang Chen
Jie Hao
Yiming Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1171582

3,328 views
4 citations

Original Research

Published on 14 Jul 2023

PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer

in Cancer Immunity and Immunotherapy

Biao Zhang
Bingqian Huang
Xiaonan Zhang
Shuang Li
Jingyi Zhu
Xu Chen
Huiyi Song
Dong Shang

Frontiers in Oncology

doi 10.3389/fonc.2023.1217654

6,966 views
23 citations

Original Research

Published on 13 Jul 2023

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Neslihan Cabioglu
Aysel Bayram
Selman Emiroglu
Semen Onder
Huseyin Karatay
Gizem Oner
Mustafa Tukenmez
Mahmut Muslumanoglu
Abdullah Igci
Adnan Aydiner

Frontiers in Oncology

doi 10.3389/fonc.2023.1165257

2,476 views
6 citations

Original Research

Published on 11 Jul 2023

A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Hongxiang Liu
Yong Luo
Shankun Zhao
Jing Tan
Minjian Chen
Xihai Liu
Jianheng Ye
Shanghua Cai
Yulin Deng
Jinchuang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1202151

3,204 views
2 citations